North America is the largest consumption place, with a consumption market share nearly 33% . Following North America, China is the second largest consumption place with the consumption market share of 26%.The key manufacturers are Chiesi Farmaceutici, CR-Double Crane, ONY Biotech, AbbVie, Yuhan Corporation, JW Pharmaceuticals, Noargen etc. Top 3 companies occupied about 85% market share.
Market Analysis and Insights: Global Respiratory Distress Syndrome Market
The global Respiratory Distress Syndrome market size is projected to reach US$ 520.8 million by 2027, from US$ 358.7 million in 2020, at a CAGR of 5.5% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Respiratory Distress Syndrome market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Respiratory Distress Syndrome market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Respiratory Distress Syndrome market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Respiratory Distress Syndrome market.
Respiratory Distress Syndrome Breakdown Data by Type
Poractant Alfa
Beractant
Calfactant
Others
Poractant Alpha's largest market share is broken down to 67%.
Respiratory Distress Syndrome Breakdown Data by Application
Very Preterm Infants
Moderate to Late Preterm Infants
Others
Very Preterm shapes the largest segment of the application market
Based on regional and country-level analysis, the Respiratory Distress Syndrome market has been segmented as follows:
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia-Pacific
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of Middle East & Africa
In the competitive analysis section of the report, leading as well as prominent players of the global Respiratory Distress Syndrome market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2016-2021. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2016-2021.
The following players are covered in this report:
Chiesi Farmaceutici
CR-Double Crane
ONY Biotech
AbbVie
Yuhan Corporation
JW Pharmaceuticals
Noargen
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Respiratory Distress Syndrome Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Poractant Alfa
1.2.3 Beractant
1.2.4 Calfactant
1.2.5 Others
1.3 Market by Application
1.3.1 Global Respiratory Distress Syndrome Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Very Preterm Infants
1.3.3 Moderate to Late Preterm Infants
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Respiratory Distress Syndrome Market Perspective (2016-2027)
2.2 Respiratory Distress Syndrome Growth Trends by Regions
2.2.1 Respiratory Distress Syndrome Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Respiratory Distress Syndrome Historic Market Share by Regions (2016-2021)
2.2.3 Respiratory Distress Syndrome Forecasted Market Size by Regions (2022-2027)
2.3 Respiratory Distress Syndrome Industry Dynamic
2.3.1 Respiratory Distress Syndrome Market Trends
2.3.2 Respiratory Distress Syndrome Market Drivers
2.3.3 Respiratory Distress Syndrome Market Challenges
2.3.4 Respiratory Distress Syndrome Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Respiratory Distress Syndrome Players by Revenue
3.1.1 Global Top Respiratory Distress Syndrome Players by Revenue (2016-2021)
3.1.2 Global Respiratory Distress Syndrome Revenue Market Share by Players (2016-2021)
3.2 Global Respiratory Distress Syndrome Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Respiratory Distress Syndrome Revenue
3.4 Global Respiratory Distress Syndrome Market Concentration Ratio
3.4.1 Global Respiratory Distress Syndrome Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Respiratory Distress Syndrome Revenue in 2020
3.5 Respiratory Distress Syndrome Key Players Head office and Area Served
3.6 Key Players Respiratory Distress Syndrome Product Solution and Service
3.7 Date of Enter into Respiratory Distress Syndrome Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Respiratory Distress Syndrome Breakdown Data by Type
4.1 Global Respiratory Distress Syndrome Historic Market Size by Type (2016-2021)
4.2 Global Respiratory Distress Syndrome Forecasted Market Size by Type (2022-2027)
5 Respiratory Distress Syndrome Breakdown Data by Application
5.1 Global Respiratory Distress Syndrome Historic Market Size by Application (2016-2021)
5.2 Global Respiratory Distress Syndrome Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Respiratory Distress Syndrome Market Size (2016-2027)
6.2 North America Respiratory Distress Syndrome Market Size by Type
6.2.1 North America Respiratory Distress Syndrome Market Size by Type (2016-2021)
6.2.2 North America Respiratory Distress Syndrome Market Size by Type (2022-2027)
6.2.3 North America Respiratory Distress Syndrome Market Size by Type (2016-2027)
6.3 North America Respiratory Distress Syndrome Market Size by Application
6.3.1 North America Respiratory Distress Syndrome Market Size by Application (2016-2021)
6.3.2 North America Respiratory Distress Syndrome Market Size by Application (2022-2027)
6.3.3 North America Respiratory Distress Syndrome Market Size by Application (2016-2027)
6.4 North America Respiratory Distress Syndrome Market Size by Country
6.4.1 North America Respiratory Distress Syndrome Market Size by Country (2016-2021)
6.4.2 North America Respiratory Distress Syndrome Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Respiratory Distress Syndrome Market Size (2016-2027)
7.2 Europe Respiratory Distress Syndrome Market Size by Type
7.2.1 Europe Respiratory Distress Syndrome Market Size by Type (2016-2021)
7.2.2 Europe Respiratory Distress Syndrome Market Size by Type (2022-2027)
7.2.3 Europe Respiratory Distress Syndrome Market Size by Type (2016-2027)
7.3 Europe Respiratory Distress Syndrome Market Size by Application
7.3.1 Europe Respiratory Distress Syndrome Market Size by Application (2016-2021)
7.3.2 Europe Respiratory Distress Syndrome Market Size by Application (2022-2027)
7.3.3 Europe Respiratory Distress Syndrome Market Size by Application (2016-2027)
7.4 Europe Respiratory Distress Syndrome Market Size by Country
7.4.1 Europe Respiratory Distress Syndrome Market Size by Country (2016-2021)
7.4.2 Europe Respiratory Distress Syndrome Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Respiratory Distress Syndrome Market Size (2016-2027)
8.2 Asia-Pacific Respiratory Distress Syndrome Market Size by Type
8.2.1 Asia-Pacific Respiratory Distress Syndrome Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Respiratory Distress Syndrome Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Respiratory Distress Syndrome Market Size by Type (2016-2027)
8.3 Asia-Pacific Respiratory Distress Syndrome Market Size by Application
8.3.1 Asia-Pacific Respiratory Distress Syndrome Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Respiratory Distress Syndrome Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Respiratory Distress Syndrome Market Size by Application (2016-2027)
8.4 Asia-Pacific Respiratory Distress Syndrome Market Size by Region
8.4.1 Asia-Pacific Respiratory Distress Syndrome Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Respiratory Distress Syndrome Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Respiratory Distress Syndrome Market Size (2016-2027)
9.2 Latin America Respiratory Distress Syndrome Market Size by Type
9.2.1 Latin America Respiratory Distress Syndrome Market Size by Type (2016-2021)
9.2.2 Latin America Respiratory Distress Syndrome Market Size by Type (2022-2027)
9.2.3 Latin America Respiratory Distress Syndrome Market Size by Type (2016-2027)
9.3 Latin America Respiratory Distress Syndrome Market Size by Application
9.3.1 Latin America Respiratory Distress Syndrome Market Size by Application (2016-2021)
9.3.2 Latin America Respiratory Distress Syndrome Market Size by Application (2022-2027)
9.3.3 Latin America Respiratory Distress Syndrome Market Size by Application (2016-2027)
9.4 Latin America Respiratory Distress Syndrome Market Size by Country
9.4.1 Latin America Respiratory Distress Syndrome Market Size by Country (2016-2021)
9.4.2 Latin America Respiratory Distress Syndrome Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Respiratory Distress Syndrome Market Size (2016-2027)
10.2 Middle East & Africa Respiratory Distress Syndrome Market Size by Type
10.2.1 Middle East & Africa Respiratory Distress Syndrome Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Respiratory Distress Syndrome Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Respiratory Distress Syndrome Market Size by Type (2016-2027)
10.3 Middle East & Africa Respiratory Distress Syndrome Market Size by Application
10.3.1 Middle East & Africa Respiratory Distress Syndrome Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Respiratory Distress Syndrome Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Respiratory Distress Syndrome Market Size by Application (2016-2027)
10.4 Middle East & Africa Respiratory Distress Syndrome Market Size by Country
10.4.1 Middle East & Africa Respiratory Distress Syndrome Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Respiratory Distress Syndrome Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Chiesi Farmaceutici
11.1.1 Chiesi Farmaceutici Company Details
11.1.2 Chiesi Farmaceutici Business Overview
11.1.3 Chiesi Farmaceutici Respiratory Distress Syndrome Introduction
11.1.4 Chiesi Farmaceutici Revenue in Respiratory Distress Syndrome Business (2016-2021)
11.1.5 Chiesi Farmaceutici Recent Development
11.2 CR-Double Crane
11.2.1 CR-Double Crane Company Details
11.2.2 CR-Double Crane Business Overview
11.2.3 CR-Double Crane Respiratory Distress Syndrome Introduction
11.2.4 CR-Double Crane Revenue in Respiratory Distress Syndrome Business (2016-2021)
11.2.5 CR-Double Crane Recent Development
11.3 ONY Biotech
11.3.1 ONY Biotech Company Details
11.3.2 ONY Biotech Business Overview
11.3.3 ONY Biotech Respiratory Distress Syndrome Introduction
11.3.4 ONY Biotech Revenue in Respiratory Distress Syndrome Business (2016-2021)
11.3.5 ONY Biotech Recent Development
11.4 AbbVie
11.4.1 AbbVie Company Details
11.4.2 AbbVie Business Overview
11.4.3 AbbVie Respiratory Distress Syndrome Introduction
11.4.4 AbbVie Revenue in Respiratory Distress Syndrome Business (2016-2021)
11.4.5 AbbVie Recent Development
11.5 Yuhan Corporation
11.5.1 Yuhan Corporation Company Details
11.5.2 Yuhan Corporation Business Overview
11.5.3 Yuhan Corporation Respiratory Distress Syndrome Introduction
11.5.4 Yuhan Corporation Revenue in Respiratory Distress Syndrome Business (2016-2021)
11.5.5 Yuhan Corporation Recent Development
11.6 JW Pharmaceuticals
11.6.1 JW Pharmaceuticals Company Details
11.6.2 JW Pharmaceuticals Business Overview
11.6.3 JW Pharmaceuticals Respiratory Distress Syndrome Introduction
11.6.4 JW Pharmaceuticals Revenue in Respiratory Distress Syndrome Business (2016-2021)
11.6.5 JW Pharmaceuticals Recent Development
11.7 Noargen
11.7.1 Noargen Company Details
11.7.2 Noargen Business Overview
11.7.3 Noargen Respiratory Distress Syndrome Introduction
11.7.4 Noargen Revenue in Respiratory Distress Syndrome Business (2016-2021)
11.7.5 Noargen Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
